Suppr超能文献

相似文献

1
Identification of cross-reactive norovirus CD4+ T cell epitopes.
J Virol. 2010 Sep;84(17):8530-8. doi: 10.1128/JVI.00727-10. Epub 2010 Jun 23.
4
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.
9
Cellular and humoral immunity following Snow Mountain virus challenge.
J Virol. 2005 Mar;79(5):2900-9. doi: 10.1128/JVI.79.5.2900-2909.2005.

引用本文的文献

2
Virus-Host Interactions Between Nonsecretors and Human Norovirus.
Cell Mol Gastroenterol Hepatol. 2020;10(2):245-267. doi: 10.1016/j.jcmgh.2020.03.006. Epub 2020 Apr 11.
6
Norovirus vaccines: Correlates of protection, challenges and limitations.
Hum Vaccin Immunother. 2016 Jul 2;12(7):1653-69. doi: 10.1080/21645515.2015.1125054. Epub 2016 Feb 2.
7
Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition.
Clin Vaccine Immunol. 2015 Jun;22(6):656-63. doi: 10.1128/CVI.00015-15. Epub 2015 Apr 22.
8
Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
PLoS One. 2013 Jul 26;8(7):e70409. doi: 10.1371/journal.pone.0070409. Print 2013.
9
Norovirus P particle efficiently elicits innate, humoral and cellular immunity.
PLoS One. 2013 Apr 29;8(4):e63269. doi: 10.1371/journal.pone.0063269. Print 2013.

本文引用的文献

1
Heterotypic humoral and cellular immune responses following Norwalk virus infection.
J Virol. 2010 Feb;84(4):1800-15. doi: 10.1128/JVI.02179-09. Epub 2009 Dec 9.
2
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
Vaccine. 2009 Dec 11;28(2):484-93. doi: 10.1016/j.vaccine.2009.09.135. Epub 2009 Oct 24.
3
Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.
J Virol. 2009 Jun;83(11):5363-74. doi: 10.1128/JVI.02518-08. Epub 2009 Mar 18.
5
Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
PLoS Pathog. 2008 Dec;4(12):e1000236. doi: 10.1371/journal.ppat.1000236. Epub 2008 Dec 12.
6
Antibody is critical for the clearance of murine norovirus infection.
J Virol. 2008 Jul;82(13):6610-7. doi: 10.1128/JVI.00141-08. Epub 2008 Apr 16.
7
Mechanisms of GII.4 norovirus persistence in human populations.
PLoS Med. 2008 Feb;5(2):e31. doi: 10.1371/journal.pmed.0050031.
8
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
Vaccine. 2006 Jun 12;24(24):5220-34. doi: 10.1016/j.vaccine.2006.03.080. Epub 2006 Apr 18.
9
Mucosal and systemic adjuvant activity of alphavirus replicon particles.
Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3722-7. doi: 10.1073/pnas.0600287103. Epub 2006 Feb 27.
10
Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.
J Virol. 2005 Jun;79(12):7402-9. doi: 10.1128/JVI.79.12.7402-7409.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验